CMC Comparability Protocols Should Allow For Broader Changes, PhRMA Says
Executive Summary
The scope of FDA's chemistry, manufacturing & controls comparability protocols should be broader if sufficient data are available, the Pharmaceutical Research & Manufacturers of America suggests